Annovis Bio, Inc. (ANVS) SEC Filings — 2024

Filings

• Annovis Bio Enters Material Definitive Agreement — 8-K · Dec 11, 2024
• Annovis Bio CEO Change and Director Departure — 8-K · Dec 9, 2024
• Annovis Bio Files 8-K on Financials — 8-K · Nov 12, 2024
• Annovis Bio Q3 2024: Cash Dips to $105.2M — 10-Q · Nov 8, 2024
• Annovis Bio Files 8-K — 8-K · Oct 15, 2024
• Annovis Bio Files 8-K for Financials and Exhibits — 8-K · Sep 30, 2024
• Annovis Bio Files 8-K on Financials — 8-K · Aug 15, 2024
• Annovis Bio Q2 2024 10-Q: Asset and Liability Update — 10-Q · Aug 14, 2024
• Annovis Bio Files 8-K — 8-K · Aug 6, 2024
• Annovis Bio Files 8-K, Updates Corporate Info — 8-K · Jul 16, 2024
• Annovis Bio Files 8-K — 8-K · Jul 10, 2024
• Annovis Bio Files 8-K — 8-K · Jul 2, 2024
• Annovis Bio Files 8-K on Security Holder Vote — 8-K · Jun 13, 2024
• Annovis Bio Prices $10M Registered Direct Offering — 8-K · Jun 11, 2024
• Annovis Bio Partners with Pfizer for Alzheimer's Drug Trial — 8-K · Jun 5, 2024
• Annovis Bio Files 8-K — 8-K · May 21, 2024
• Annovis Bio Files 8-K on Financials — 8-K · May 13, 2024
• Annovis Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
• Annovis Bio Files 8-K for Financial Statements — 8-K · May 9, 2024
• Annovis Bio Files 8-K — 8-K · May 6, 2024
• Annovis Bio Files 8-K — 8-K · May 2, 2024
• Annovis Bio Files 8-K: Board and Compensation Updates — 8-K · May 1, 2024
• Annovis Bio, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
• Annovis Bio Enters Material Definitive Agreement — 8-K · Apr 26, 2024
• Annovis Bio Files 8-K on Financials — 8-K · Apr 3, 2024
• Annovis Bio, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
• Annovis Bio Partners with Pfizer for Alzheimer's Trial — 8-K · Mar 22, 2024
• Annovis Bio Enters Material Definitive Agreement — 8-K · Mar 21, 2024
• Annovis Bio Partners with Pfizer for Alzheimer's Trial — 8-K · Mar 20, 2024
• Annovis Bio Files 8-K for Material Agreement — 8-K · Mar 15, 2024